Comparing Treatment Plans for Bladder Cancer: FIF, IMRT and SIB: A Dosimetric Study
İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi · 29.04.2026 · (28) · 57-68
DOI: 10.38079/igusabder.1628465 ↗Kurz gefasst
Fachartikel in der Zeitschrift İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi, online erschienen am 29.04.2026. Verfasst von Gökçen İnan und 2 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Aim
The purpose of this study is to compare plans for bladder cancer using field-in-field (FIF), intensity modulated radiotherapy (IMRT) and simultaneous integrated boost (SIB) technique.
Method
FIF, IMRT and SIB treatment plans were created using tomography images of 20 patients diagnosed with bladder cancer. Two separate planning target volume (PTV) were defined for each patient: PTV1 and PTV2. For the FIF and IMRT plans, PTV1 and PTV2 received treatment doses of 50.4 Gray (Gy) and 60 Gy in 33 fractions, respectively. In 28 daily fractions, the SIB method was used in which different doses were delivered simultaneously in the target volumes. In the SIB technique, the daily treatment dose was determined as 2.14 Gy. The plans were compared in terms of PTV, organs at risk (OARs) such as rectum, bowel, femoral heads, homogeneity index (HI), conformity index (CI) and monitor unit values (MU).
Results
All plans were designed to cover 95% of the dose in the target volume. The CI for SIB plans showed significantly favourable results compared to FIF and IMRT plans. The V45 and V30 doses for the rectum in the SIB plans were statistically significantly lower compared to the FIF (p<0.05). The biologically effective doses (BED) values of rectum V30 were found to be 57.01±11.94 in SIB plans and 56.37±10.95 in IMRT plans. MU counts were significantly lower in FIF plans (p<0.05).
Conclusion
The SIB technique demonstrated better sparing of critical organs compared with FIF and IMRT in bladder radiotherapy. BED analysis, however, indicated higher doses with SIB. Overall, SIB appears to be a feasible option for appropriate patients, provided that dose to critical organs is carefully monitored.
Zitieren
APA
İnan, G., Gül, O. V., & Başaran, H. (2026). Comparing Treatment Plans for Bladder Cancer: FIF, IMRT and SIB: A Dosimetric Study. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi, 57-68. https://doi.org/10.38079/igusabder.1628465
Vancouver
İnan G, Gül OV, Başaran H. Comparing Treatment Plans for Bladder Cancer: FIF, IMRT and SIB: A Dosimetric Study. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi. 2026:57-68. doi:10.38079/igusabder.1628465
BibTeX
@article{nan2026,
author = {İnan, Gökçen and Gül, Osman Vefa and Başaran, Hamit},
title = {Comparing Treatment Plans for Bladder Cancer: FIF, IMRT and SIB: A Dosimetric Study},
journal = {İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi},
year = {2026},
number = {28},
pages = {57--68},
doi = {10.38079/igusabder.1628465}
}
EUVIMED